Residual Income / EVA
Residual income (RI) and its corporate-finance twin, Economic Value Added (EVA), rest on a single insight that ordinary accounting profit ignores: capital is not free. A company only creates value when it earns more than the return its capital providers could have gotten elsewhere. Net income can be positive while the firm is quietly destroying value, because reported earnings deduct interest but never charge for the equity shareholders supplied. Residual income subtracts that missing charge — the equity cost — and EVA extends the idea to total invested capital. The core tension is that the concept is theoretically clean and intuitively powerful, yet in practice it depends on a chain of contestable inputs (cost of capital, book-value adjustments, normalized earnings) that make it as fragile as the DCF it claims to improve on.
How it's calculated / formed
Residual income (equity perspective):
> RI = Net Income − (Equity Capital × Cost of Equity)
The "equity charge" is typically beginning book value of equity multiplied by the cost of equity (often estimated via CAPM). Positive RI means the firm out-earned its shareholders' required return; negative RI signals value destruction even if net income is positive.
The residual income valuation model (RIM), from Edwards-Bell-Ohlson:
> V₀ = B₀ + Σ [ RIₜ / (1 + r)ᵗ ]
Intrinsic equity value = current book value of equity (B₀) plus the present value of all future residual incomes, discounted at the cost of equity (r). Most of the value is "anchored" in book value rather than pushed into a distant terminal value.
Economic Value Added (EVA), developed and trademarked by Stern Stewart & Co. in the late 1980s, applies the same logic at the firm (total-capital) level:
> EVA = NOPAT − (WACC × Invested Capital) = (ROIC − WACC) × Invested Capital
where NOPAT is net operating profit after taxes (operating profit, before financing), WACC is the weighted-average cost of capital, and the "capital charge" is WACC × the economic capital employed. Stern Stewart prescribes a long list of accounting-to-economics adjustments — capitalizing R&D and advertising, undoing goodwill amortization, treating leases and deferred taxes as capital, etc. Sources commonly cite "over 160" potential adjustments, though in practice only a handful are applied (per Wikipedia and Stern Stewart materials).
How it's used in practice
Two distinct uses, often conflated:
1. Equity valuation (RIM). Analysts use it as an alternative to dividend discount and DCF models. Its signature advantage: because value is anchored in current book value, it is well suited to firms that pay no dividends, have erratic payouts, or have negative near-term free cash flow — exactly the cases where DDM and DCF strain. Under clean-surplus accounting (all changes in book equity flow through earnings except transactions with owners), RIM is mathematically equivalent to DCF and should yield the same value for identical assumptions; DCF is effectively a special case using cash accounting (The Footnotes Analyst; Penman, Columbia).
2. Corporate performance management & incentive design. This is EVA's home turf. Firms use it as a single internal metric tying divisional performance and executive bonuses to value creation, on the theory that charging managers for capital curbs empire-building and low-return investment. Consulting practices (Stern Stewart, now Stern Value Management) built businesses around installing EVA-based management systems in the 1990s.
Adoption, debate & evidence
EVA had a major vogue in the 1990s — popularized by Fortune ("the real key to creating wealth") and adopted by companies such as Coca-Cola — but its corporate adoption faded, and it never displaced earnings/EPS as the headline metric markets watch. RIM remains a standard tool in the CFA curriculum and academic valuation, more respected by scholars than by practitioners, who lean on DCF and multiples.
The central marketing claim — that EVA is superior to accounting earnings at explaining shareholder wealth — does not survive the evidence. The most-cited test, Biddle, Bowen & Wallace (1997), "Does EVA® beat earnings?" (Journal of Accounting and Economics), found that earnings are more highly associated with stock returns and firm values than EVA, residual income, or operating cash flow; EVA's unique components added only marginal incremental information content. Earlier Stern-Stewart-affiliated work (Lehn & Makhija, 1996/1997) reported EVA had a "slight edge," but the preponderance of independent studies since finds traditional measures (EPS, ROE, ROA, net income) explain returns at least as well or better, with several finding weak or no reliable EVA–return relation. The honest summary: EVA/RI is a sound conceptual and governance framework, but there is no robust evidence it is a better predictor of stock returns than ordinary earnings. Folklore says "EVA beats earnings"; the measured base rate says it does not.
Strengths & limitations
Strengths. Forces an explicit, correct charge for all capital including equity — the conceptual fix to a real accounting blind spot. Anchors valuation in book value, reducing reliance on a speculative terminal value (a genuine DCF weakness). Handles non-dividend-paying and negative-FCF firms gracefully. As a management metric, aligns incentives with capital efficiency.
Limitations. (a) It is only as good as the cost of capital — small changes in r or WACC swing both the equity charge and the discounted value substantially. (b) It inherits all of accounting's distortions: book value understates firms with large unrecognized intangibles (brands, R&D), so RI/EVA can mislead for asset-light businesses unless adjusted — and the adjustments are subjective and inconsistent. (c) The clean-surplus assumption is violated in real GAAP/IFRS statements (OCI items bypass earnings), breaking the DCF equivalence. (d) As a single-period bonus metric, EVA can encourage short-termism — cutting capital or R&D to flatter the capital charge.
The #1 misuse: treating EVA/RI as a market-beating stock-selection signal. It was designed as a value-measurement and incentive framework, not an empirically validated return predictor — and the literature does not back that use.
Sources
- Biddle, Bowen & Wallace (1997), "Does EVA® beat earnings? Evidence on associations with stock returns and firm values," J. of Accounting and Economics — primary empirical test: SSRN / ScienceDirect
- CFA Institute, Residual Income Valuation refresher reading: cfainstitute.org
- Corporate Finance Institute, Residual Income Valuation: corporatefinanceinstitute.com
- Wikipedia, Economic Value Added (formula, Stern Stewart origin, adjustments): en.wikipedia.org
- The Footnotes Analyst, "DCF versus residual income" (clean-surplus equivalence): footnotesanalyst.com
- Penman, "Valuation Models: An Issue of Accounting Theory," Columbia Business School: business.columbia.edu
Disputes flagged: EVA's claimed superiority over earnings is genuinely contested — Stern-Stewart-affiliated studies (Lehn & Makhija) are more favorable than independent work (Biddle et al. and subsequent emerging-market studies), and the doc sides with the independent academic consensus.